| Dr Cody Stark Rogers, MD | |
|
525 Branson Landing Blvd, Branson, MO 65616-2052 | |
| (417) 335-7128 | |
| (417) 348-8007 |
| Full Name | Dr Cody Stark Rogers |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 7 Years |
| Location | 525 Branson Landing Blvd, Branson, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063943587 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2019003806 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cox Medical Center Branson | Branson, MO | Hospital |
| North Arkansas Regional Medical Center | Harrison, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Skaggs Community Hospital Association | 5092624320 | 133 |
News Archive
The IPAB has created "immediate uncertainty at hand," says Scott & White Healthcare in central Texas, for their 12 hospitals and more than 800 physicians. Many more organizations and associations have expressed similar concerns and urged me to do what I can to repeal this ill-conceived bureaucratic board. That's why I have introduced the Health Care Bureaucrats Elimination Act, and why I'm testifying Wednesday on the other side of the Capitol to build support in the House.
No one knows for sure how long they will live. A new study, however, suggests that leukocyte telomere length may offer some key insights into a woman's longevity and further demonstrates how maternal age at birth of last child affects telomere length and long-term health.
Dr. Chris Berger, CMB Interim Director and Director of Graduate Education for the College of Medicine, announced the winner of the 2014 Norman R. Alpert Award at the annual Graduate Research Day for the CMB Program event held October 2, 2014. Jacqueline Leung, a graduate student in the Cellular, Molecular and Biosciences (CMB) Program at the University of Vermont won for her publication, "Identification of T. gondii Myosin Light Chain-1 as a Direct Target of TachypleginA-2, a Small-Molecule Inhibitor of Parasite Motility and Invasion."1
Researchers at 17 medical centers across the country soon will begin using the hormone progesterone to treat patients who experience traumatic brain injury (TBI). The treatment is part of a randomized, double-blind Phase III clinical trial that will enroll approximately 1,140 people over a three- to six-year period beginning in March, 2010. The trial is funded by a grant to Emory University from the National Institutes of Health.
› Verified 3 days ago
| Entity Name | Nevada City Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942283866 PECOS PAC ID: 9830095280 Enrollment ID: O20031208001009 |
News Archive
The IPAB has created "immediate uncertainty at hand," says Scott & White Healthcare in central Texas, for their 12 hospitals and more than 800 physicians. Many more organizations and associations have expressed similar concerns and urged me to do what I can to repeal this ill-conceived bureaucratic board. That's why I have introduced the Health Care Bureaucrats Elimination Act, and why I'm testifying Wednesday on the other side of the Capitol to build support in the House.
No one knows for sure how long they will live. A new study, however, suggests that leukocyte telomere length may offer some key insights into a woman's longevity and further demonstrates how maternal age at birth of last child affects telomere length and long-term health.
Dr. Chris Berger, CMB Interim Director and Director of Graduate Education for the College of Medicine, announced the winner of the 2014 Norman R. Alpert Award at the annual Graduate Research Day for the CMB Program event held October 2, 2014. Jacqueline Leung, a graduate student in the Cellular, Molecular and Biosciences (CMB) Program at the University of Vermont won for her publication, "Identification of T. gondii Myosin Light Chain-1 as a Direct Target of TachypleginA-2, a Small-Molecule Inhibitor of Parasite Motility and Invasion."1
Researchers at 17 medical centers across the country soon will begin using the hormone progesterone to treat patients who experience traumatic brain injury (TBI). The treatment is part of a randomized, double-blind Phase III clinical trial that will enroll approximately 1,140 people over a three- to six-year period beginning in March, 2010. The trial is funded by a grant to Emory University from the National Institutes of Health.
› Verified 3 days ago
| Entity Name | Texas County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790740363 PECOS PAC ID: 9436041696 Enrollment ID: O20040401000307 |
News Archive
The IPAB has created "immediate uncertainty at hand," says Scott & White Healthcare in central Texas, for their 12 hospitals and more than 800 physicians. Many more organizations and associations have expressed similar concerns and urged me to do what I can to repeal this ill-conceived bureaucratic board. That's why I have introduced the Health Care Bureaucrats Elimination Act, and why I'm testifying Wednesday on the other side of the Capitol to build support in the House.
No one knows for sure how long they will live. A new study, however, suggests that leukocyte telomere length may offer some key insights into a woman's longevity and further demonstrates how maternal age at birth of last child affects telomere length and long-term health.
Dr. Chris Berger, CMB Interim Director and Director of Graduate Education for the College of Medicine, announced the winner of the 2014 Norman R. Alpert Award at the annual Graduate Research Day for the CMB Program event held October 2, 2014. Jacqueline Leung, a graduate student in the Cellular, Molecular and Biosciences (CMB) Program at the University of Vermont won for her publication, "Identification of T. gondii Myosin Light Chain-1 as a Direct Target of TachypleginA-2, a Small-Molecule Inhibitor of Parasite Motility and Invasion."1
Researchers at 17 medical centers across the country soon will begin using the hormone progesterone to treat patients who experience traumatic brain injury (TBI). The treatment is part of a randomized, double-blind Phase III clinical trial that will enroll approximately 1,140 people over a three- to six-year period beginning in March, 2010. The trial is funded by a grant to Emory University from the National Institutes of Health.
› Verified 3 days ago
| Entity Name | Skaggs Community Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861423683 PECOS PAC ID: 5092624320 Enrollment ID: O20040811000689 |
News Archive
The IPAB has created "immediate uncertainty at hand," says Scott & White Healthcare in central Texas, for their 12 hospitals and more than 800 physicians. Many more organizations and associations have expressed similar concerns and urged me to do what I can to repeal this ill-conceived bureaucratic board. That's why I have introduced the Health Care Bureaucrats Elimination Act, and why I'm testifying Wednesday on the other side of the Capitol to build support in the House.
No one knows for sure how long they will live. A new study, however, suggests that leukocyte telomere length may offer some key insights into a woman's longevity and further demonstrates how maternal age at birth of last child affects telomere length and long-term health.
Dr. Chris Berger, CMB Interim Director and Director of Graduate Education for the College of Medicine, announced the winner of the 2014 Norman R. Alpert Award at the annual Graduate Research Day for the CMB Program event held October 2, 2014. Jacqueline Leung, a graduate student in the Cellular, Molecular and Biosciences (CMB) Program at the University of Vermont won for her publication, "Identification of T. gondii Myosin Light Chain-1 as a Direct Target of TachypleginA-2, a Small-Molecule Inhibitor of Parasite Motility and Invasion."1
Researchers at 17 medical centers across the country soon will begin using the hormone progesterone to treat patients who experience traumatic brain injury (TBI). The treatment is part of a randomized, double-blind Phase III clinical trial that will enroll approximately 1,140 people over a three- to six-year period beginning in March, 2010. The trial is funded by a grant to Emory University from the National Institutes of Health.
› Verified 3 days ago
| Entity Name | Lester E Cox Medical Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538334396 PECOS PAC ID: 1254248917 Enrollment ID: O20050624000293 |
News Archive
The IPAB has created "immediate uncertainty at hand," says Scott & White Healthcare in central Texas, for their 12 hospitals and more than 800 physicians. Many more organizations and associations have expressed similar concerns and urged me to do what I can to repeal this ill-conceived bureaucratic board. That's why I have introduced the Health Care Bureaucrats Elimination Act, and why I'm testifying Wednesday on the other side of the Capitol to build support in the House.
No one knows for sure how long they will live. A new study, however, suggests that leukocyte telomere length may offer some key insights into a woman's longevity and further demonstrates how maternal age at birth of last child affects telomere length and long-term health.
Dr. Chris Berger, CMB Interim Director and Director of Graduate Education for the College of Medicine, announced the winner of the 2014 Norman R. Alpert Award at the annual Graduate Research Day for the CMB Program event held October 2, 2014. Jacqueline Leung, a graduate student in the Cellular, Molecular and Biosciences (CMB) Program at the University of Vermont won for her publication, "Identification of T. gondii Myosin Light Chain-1 as a Direct Target of TachypleginA-2, a Small-Molecule Inhibitor of Parasite Motility and Invasion."1
Researchers at 17 medical centers across the country soon will begin using the hormone progesterone to treat patients who experience traumatic brain injury (TBI). The treatment is part of a randomized, double-blind Phase III clinical trial that will enroll approximately 1,140 people over a three- to six-year period beginning in March, 2010. The trial is funded by a grant to Emory University from the National Institutes of Health.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cody Stark Rogers, MD Po Box 802843, Kansas City, MO 64180-2843 Ph: (417) 730-6430 | Dr Cody Stark Rogers, MD 525 Branson Landing Blvd, Branson, MO 65616-2052 Ph: (417) 335-7128 |
News Archive
The IPAB has created "immediate uncertainty at hand," says Scott & White Healthcare in central Texas, for their 12 hospitals and more than 800 physicians. Many more organizations and associations have expressed similar concerns and urged me to do what I can to repeal this ill-conceived bureaucratic board. That's why I have introduced the Health Care Bureaucrats Elimination Act, and why I'm testifying Wednesday on the other side of the Capitol to build support in the House.
No one knows for sure how long they will live. A new study, however, suggests that leukocyte telomere length may offer some key insights into a woman's longevity and further demonstrates how maternal age at birth of last child affects telomere length and long-term health.
Dr. Chris Berger, CMB Interim Director and Director of Graduate Education for the College of Medicine, announced the winner of the 2014 Norman R. Alpert Award at the annual Graduate Research Day for the CMB Program event held October 2, 2014. Jacqueline Leung, a graduate student in the Cellular, Molecular and Biosciences (CMB) Program at the University of Vermont won for her publication, "Identification of T. gondii Myosin Light Chain-1 as a Direct Target of TachypleginA-2, a Small-Molecule Inhibitor of Parasite Motility and Invasion."1
Researchers at 17 medical centers across the country soon will begin using the hormone progesterone to treat patients who experience traumatic brain injury (TBI). The treatment is part of a randomized, double-blind Phase III clinical trial that will enroll approximately 1,140 people over a three- to six-year period beginning in March, 2010. The trial is funded by a grant to Emory University from the National Institutes of Health.
› Verified 3 days ago
Saima Rehman Qureshi, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2715 W 76 Country Blvd Ste 103, Branson, MO 65616 Phone: 417-317-5318 | |
Roy Jack Gillispie, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 5136 Hwy 265, Branson, MO 65616 Phone: 417-338-0960 Fax: 417-338-0968 | |
Alok Shukla, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1140 W Highway 76, Branson, MO 65616 Phone: 417-317-5318 Fax: 417-763-3370 | |
Jeremy D Mabe, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1150 State Highway 248, Ste. 202, Branson, MO 65616 Phone: 417-348-8964 Fax: 417-336-0275 | |
Sabera Shabnam, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 525 Branson Landing Blvd Ste 201a, Branson, MO 65616 Phone: 417-335-7128 Fax: 417-348-8007 | |
Dr. Lisa Requena, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 525 Branson Landing Blvd, Branson, MO 65616 Phone: 417-348-8646 Fax: 417-335-7529 |